Alternaria proteases and protease defenses in asthma
Alternaria proteases and protease defenses in asthma
批准号:
8686718
负责人:
MICHAEL O DAINES
金额:
$37.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2016-06-30
关键词:
AcuteAllergensAllergicAlternariaAsthmaBenignBindingBiologicalBiologyCell AdhesionCell LineCell physiologyChildChildhood AsthmaChronicCleaved cellClinicalDataDevelopmentDiseaseElementsEpithelialEpithelial CellsEpitheliumEquilibriumExposure toExtrinsic asthmaGenerationsGeneticHumanHuman CharacteristicsInflammationInflammatory Response PathwayLeadLung InflammationModelingMoldsMusPathogenesisPeptide HydrolasesPeptidesPermeabilityPhenotypePrimary PreventionProtease InhibitorProteinsProteomicsPyroglyphidaeReceptor CellReproduction sporesRoleSerine Proteinase InhibitorsSerpinsSignal TransductionStructureStructure of respiratory epitheliumSurfaceTight JunctionsTissuesairway epitheliumairway hyperresponsivenessairway inflammationairway obstructiongrass pollenin vitro Assayin vivoinhibitor/antagonistnovelpathogenreceptorrelease of sequestered calcium ion into cytoplasmresponsestefin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Allergic asthma is a disease that impacts the lives of millions and is created by critical intersections of clinical, environmental, biologic, and genetic factors. Allergen exposure is essential to the development of allergic asthma, but not all allergens associate with asthma. One allergen central to the development of allergic asthma, especially in children, is Alternaria, a common mold. A critical feature of Alternaria differentiating it from more benign allergens is protease activity. The proteases in Alternaria increase its biological activity by disrupting epithelial cell tight junctions, activating epithelial cells, and increasing lung inflammation. There are endogenous inhibitors of proteases, including SERine Protease INhibitors (Serpins) and Stefin protease inhibitors. These inhibitors are strongly upregulated with Alternaria exposure. The Central Hypothesis of this application is that Alternaria proteases are essential to Alternaria acting as an asthmagen by directly targeting the epithelium but these effects are modulated by Alternaria-induced host antiproteases. We will utilize proteomics, in vitro assays, and murine models of Alternaria-induced lung inflammation to assess the interaction of the epithelium and host antiproteases with Alternaria proteases and determine their impact on the development of allergic asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alternaria proteases and protease defenses in asthma
-
批准号:8870274
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2011
-
负责人:MICHAEL O DAINES
-
依托单位:
Alternaria proteases and protease defenses in asthma
-
批准号:8293027
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2011
-
负责人:MICHAEL O DAINES
-
依托单位:
Alternaria proteases and protease defenses in asthma
-
批准号:8481505
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2011
-
负责人:MICHAEL O DAINES
-
依托单位:
Alternaria proteases and protease defenses in asthma
-
批准号:8039797
-
项目类别:
-
资助金额:$31.56万
-
财政年份:2011
-
负责人:MICHAEL O DAINES
-
依托单位:
Alternaria proteases and protease defenses in asthma
-
批准号:8140393
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2010
-
负责人:MICHAEL O DAINES
-
依托单位:
Biology and regulation of Il-13 receptor alpha 2
-
批准号:6755884
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2003
-
负责人:MICHAEL O DAINES
-
依托单位:
Biology and regulation of Il-13 receptor alpha 2
-
批准号:7095930
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2003
-
负责人:MICHAEL O DAINES
-
依托单位:
Biology and regulation of Il-13 receptor alpha 2
-
批准号:6901834
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2003
-
负责人:MICHAEL O DAINES
-
依托单位:
Biology and regulation of IL-13 receptor alpha 2
-
批准号:6686211
-
项目类别:
-
资助金额:$10.88万
-
财政年份:2003
-
负责人:MICHAEL O DAINES
-
依托单位:
Biology and regulation of Il-13 receptor alpha 2
-
批准号:7361817
-
项目类别:
-
资助金额:$10.71万
-
财政年份:2003
-
负责人:MICHAEL O DAINES
-
依托单位:
海外基金